PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1337622
PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1337622
Amniotic Products Market Size and Share Research Report by Type, Application, End User - Global Industry Demand Forecast to 2030
The amniotic products market was USD 810.4 million in 2022, and it will advance at an 8.7% compound annual growth rate, to touch USD 1,451.2 million, by 2030.
The growth of the industry is ascribed to the continuing research to enlarge the application area, utilization of these products for the treatment of eye and skin illnesses, and increasing prevalence of traumatic wounds and injuries because of burns, as well as the rising consciousness about the usage of amniotic products for their treatment.
In 2022, the membranes category, based on type, accounted for the largest share of the industry, of 80%. This is credited to the superior effectiveness of membranes over suspensions. Moreover, the category will advance at an exponential rate because of the increasing utilization of such membranes for various ophthalmic problems.
In 2022, the surgical wounds category, based on application, accounted for the largest amniotic products market share, of 60%. This is because of the mounting number of ulcers and burn injuries, surging cases of surgical and traumatic wounds, and increasing requirement for new technologies to treat them.
Moreover, a surging number of surgical procedures has been witnessed all over the world due to the rising incidence of infectious and chronic illnesses, which has created rewarding potential for growth in the industry.
In 2022, the hospital category, based on end users, accounted for the largest share, of 55%. This is because patients often visit hospitals as they are the primary settings for healthcare that make various illnesses easy to treat.
The specialty clinics category is expected to observe a high rate of growth in the years to come. This is attributed to the extensive usage of amniotic membranes in specialty clinics, such as plastic surgery, burn facilities, and dermatology, to stop infections and enhance wound healing.
In 2022, the North American amniotic products industry was the largest contributor, with a 60% share. This is primarily attributed to the existence of well-established healthcare facilities and key industry players. Moreover, the surging focus being given to alternative technologies will further boost the growth of the regional industry.
APAC is likely to witness the fastest growth, with a 9% compound annual growth rate, in the years to come. This can be attributed to the rising disposable income and the economic growth across the nations of the region.
Moreover, several global companies are making notable findings in this area. Large unmet requirements and rising infrastructure of healthcare, mainly in India and Japan, will further boost the growth of the regional industry.
It is because of the increasing prevalence of traumatic wounds and injuries because of burns and the surging treatment for skin and eye disorders, the amniotic products industry will continue to advance in the years to come.
Table of Contents
Chapter 1. Research Scope
- 1.1. Research Objectives
- 1.2. Market Definition
- 1.3. Analysis Period
- 1.4. Market Size Breakdown by Segments
- 1.4.1. Market size breakdown, by type
- 1.4.2. Market size breakdown, by application
- 1.4.3. Market size breakdown, by end user
- 1.4.4. Market size breakdown, by region
- 1.4.5. Market size breakdown, by country
- 1.5. Market Data Reporting Unit
- 1.5.1. Value
- 1.6. Key Stakeholders
Chapter 2. Research Methodology
- 2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence database
- 2.2. Primary Research
- 2.3. Market Size Estimation
- 2.4. Data Triangulation
- 2.5. Currency Conversion Rates
- 2.6. Assumptions for the Study
- 2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Voice of Industry Experts/KOLs
Chapter 5. Market Indicators
Chapter 6. Industry Outlook
- 6.1. Market Dynamics
- 6.1.1. Trends
- 6.1.2. Drivers
- 6.1.3. Restraints/challenges
- 6.1.4. Impact analysis of drivers/restraints
- 6.2. Impact of COVID-19
- 6.3. Porter's Five Forces Analysis
- 6.3.1. Bargaining power of buyers
- 6.3.2. Bargaining power of suppliers
- 6.3.3. Threat of new entrants
- 6.3.4. Intensity of rivalry
- 6.3.5. Threat of substitutes
Chapter 7. Global Market
- 7.1. Overview
- 7.2. Market Revenue, by Type (2017-2030)
- 7.3. Market Revenue, by Application (2017-2030)
- 7.4. Market Revenue, by End user (2017-2030)
- 7.5. Market Revenue, by Region (2017-2030)
Chapter 8. North America Market
- 8.1. Overview
- 8.2. Market Revenue, by Type (2017-2030)
- 8.3. Market Revenue, by Application (2017-2030)
- 8.4. Market Revenue, by End user (2017-2030)
- 8.5. Market Revenue, by Country (2017-2030)
Chapter 9. Europe Market
- 9.1. Overview
- 9.2. Market Revenue, by Type (2017-2030)
- 9.3. Market Revenue, by Application (2017-2030)
- 9.4. Market Revenue, by End user (2017-2030)
- 9.5. Market Revenue, by Country (2017-2030)
Chapter 10. APAC Market
- 10.1. Overview
- 10.2. Market Revenue, by Type (2017-2030)
- 10.3. Market Revenue, by Application (2017-2030)
- 10.4. Market Revenue, by End user (2017-2030)
- 10.5. Market Revenue, by Country (2017-2030)
Chapter 11. LATAM Market
- 11.1. Overview
- 11.2. Market Revenue, by Type (2017-2030)
- 11.3. Market Revenue, by Application (2017-2030)
- 11.4. Market Revenue, by End user (2017-2030)
- 11.5. Market Revenue, by Country (2017-2030)
Chapter 12. MEA Market
- 12.1. Overview
- 12.2. Market Revenue, by Type (2017-2030)
- 12.3. Market Revenue, by Application (2017-2030)
- 12.4. Market Revenue, by End user (2017-2030)
- 12.5. Market Revenue, by Country (2017-2030)
Chapter 13. U.S. Market
- 13.1. Overview
- 13.2. Market Revenue, by Type (2017-2030)
- 13.3. Market Revenue, by Application (2017-2030)
- 13.4. Market Revenue, by End user (2017-2030)
Chapter 14. Canada Market
- 14.1. Overview
- 14.2. Market Revenue, by Type (2017-2030)
- 14.3. Market Revenue, by Application (2017-2030)
- 14.4. Market Revenue, by End user (2017-2030)
Chapter 15. Germany Market
- 15.1. Overview
- 15.2. Market Revenue, by Type (2017-2030)
- 15.3. Market Revenue, by Application (2017-2030)
- 15.4. Market Revenue, by End user (2017-2030)
Chapter 16. France Market
- 16.1. Overview
- 16.2. Market Revenue, by Type (2017-2030)
- 16.3. Market Revenue, by Application (2017-2030)
- 16.4. Market Revenue, by End user (2017-2030)
Chapter 17. U.K. Market
- 17.1. Overview
- 17.2. Market Revenue, by Type (2017-2030)
- 17.3. Market Revenue, by Application (2017-2030)
- 17.4. Market Revenue, by End user (2017-2030)
Chapter 18. Italy Market
- 18.1. Overview
- 18.2. Market Revenue, by Type (2017-2030)
- 18.3. Market Revenue, by Application (2017-2030)
- 18.4. Market Revenue, by End user (2017-2030)
Chapter 19. Spain Market
- 19.1. Overview
- 19.2. Market Revenue, by Type (2017-2030)
- 19.3. Market Revenue, by Application (2017-2030)
- 19.4. Market Revenue, by End user (2017-2030)
Chapter 20. Japan Market
- 20.1. Overview
- 20.2. Market Revenue, by Type (2017-2030)
- 20.3. Market Revenue, by Application (2017-2030)
- 20.4. Market Revenue, by End user (2017-2030)
Chapter 21. China Market
- 21.1. Overview
- 21.2. Market Revenue, by Type (2017-2030)
- 21.3. Market Revenue, by Application (2017-2030)
- 21.4. Market Revenue, by End user (2017-2030)
Chapter 22. India Market
- 22.1. Overview
- 22.2. Market Revenue, by Type (2017-2030)
- 22.3. Market Revenue, by Application (2017-2030)
- 22.4. Market Revenue, by End user (2017-2030)
Chapter 23. Australia Market
- 23.1. Overview
- 23.2. Market Revenue, by Type (2017-2030)
- 23.3. Market Revenue, by Application (2017-2030)
- 23.4. Market Revenue, by End user (2017-2030)
Chapter 24. South Korea Market
- 24.1. Overview
- 24.2. Market Revenue, by Type (2017-2030)
- 24.3. Market Revenue, by Application (2017-2030)
- 24.4. Market Revenue, by End user (2017-2030)
Chapter 25. Brazil Market
- 25.1. Overview
- 25.2. Market Revenue, by Type (2017-2030)
- 25.3. Market Revenue, by Application (2017-2030)
- 25.4. Market Revenue, by End user (2017-2030)
Chapter 26. Mexico Market
- 26.1. Overview
- 26.2. Market Revenue, by Type (2017-2030)
- 26.3. Market Revenue, by Application (2017-2030)
- 26.4. Market Revenue, by End user (2017-2030)
Chapter 27. Saudi Arabia Market
- 27.1. Overview
- 27.2. Market Revenue, by Type (2017-2030)
- 27.3. Market Revenue, by Application (2017-2030)
- 27.4. Market Revenue, by End user (2017-2030)
Chapter 28. South Africa Market
- 28.1. Overview
- 28.2. Market Revenue, by Type (2017-2030)
- 28.3. Market Revenue, by Application (2017-2030)
- 28.4. Market Revenue, by End user (2017-2030)
Chapter 29. U.A.E. Market
- 29.1. Overview
- 29.2. Market Revenue, by Type (2017-2030)
- 29.3. Market Revenue, by Application (2017-2030)
- 29.4. Market Revenue, by End user (2017-2030)
Chapter 30. Competitive Landscape
- 30.1. List of Market Players and their Offerings
- 30.2. Competitive Benchmarking of Key Players
- 30.3. Product Benchmarking of Key Players
- 30.4. Recent Strategic Developments
Chapter 31. Company Profiles
- 31.1. MIMEDX Group, Inc
- 31.1.1. Business overview
- 31.1.2. Product and service offerings
- 31.1.3. Key financial summary
- 31.2. VIVEX Biologics, Inc
- 31.2.1. Business overview
- 31.2.2. Product and service offerings
- 31.3. Organogenesis Holdings Inc
- 31.3.1. Business overview
- 31.3.2. Product and service offerings
- 31.3.3. Key financial summary
- 31.4. Integra Lifesciences Holdings Corporation
- 31.4.1. Business overview
- 31.4.2. Product and service offerings
- 31.4.3. Key financial summary
- 31.5. Stryker Corporation
- 31.5.1. Business overview
- 31.5.2. Product and service offerings
- 31.5.3. Key financial summary
- 31.6. Applied Biologics
- 31.6.1. Business overview
- 31.6.2. Product and service offerings
- 31.7. Celularity Inc
- 31.7.1. Business overview
- 31.7.2. Product and service offerings
- 31.7.3. Key financial summary
- 31.8. Skye Biologics Holdings, LLC
- 31.8.1. Business overview
- 31.8.2. Product and service offerings
- 31.9. Lucina BioSciences, LLC
- 31.9.1. Business overview
- 31.9.2. Product and service offerings
- 31.10. Next Biosciences
- 31.10.1. Business overview
- 31.10.2. Product and service offerings
- 31.11. TissueTech, Inc
- 31.11.1. Business overview
- 31.11.2. Product and service offerings
- 31.11.3. Key financial summary
- 31.12. Corza Ophthalmology
- 31.12.1. Business overview
- 31.12.2. Product and service offerings
- 31.13. Merakris Therapeutics, Inc
- 31.13.1. Business overview
- 31.13.2. Product and service offerings
- 31.14. Ventris Medical, LLC
- 31.14.1. Business overview
- 31.14.2. Product and service offerings
- 31.15. Tides Medical
- 31.15.1. Business overview
- 31.15.2. Product and service offerings
Chapter 32. Appendix
- 32.1. Abbreviations
- 32.2. Sources and References
- 32.3. Related Reports
